Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03395 |
| Species: | Mus musculus |
| Position : | chr7:126416668-126416932 |
| Year: | 2008 |
| Title: | Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 18552207 |
| Tissue: | thymus |
| Tissue Ontology ID: | UBERON:0002370 |
| Cell Source: | Primary thymocytes |
| Cell Type: | T cell |
| Cell Ontology ID: | CL:0000084 |
| Experiment Type: | TF binding assay; Chromatin accessibility assay |
| Low Throughput Method: | DNase I hypersensitivity assay; ChIP; in vivo DMS footprinting; LM-PCR |
| Target gene : | Cd19 |
| TF name : | Tcf3 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Tcf3 | CDO in myogenesis | reactome | 29 |
| Tcf3 | ID | netpath | 38 |
| Tcf3 | Notch-mediated HES/HEY network | pid | 48 |
| Tcf3 | Notch | netpath | 76 |
| Tcf3 | p38 signaling mediated by MAPKAP kinases | pid | 21 |
| Tcf3 | Regulation of nuclear SMAD2/3 signaling | pid | 82 |
| Tcf3 | Wnt | netpath | 118 |
| Tcf3 | Hs_Ectoderm_Differentiation_WP2858_89329 | wikipathways | 56 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03392 | chr7:126416668-126416932 | bone marrow | hematopoietic multipotent progenitor cell | NA |
| E_03393 | chr7:126416668-126416932 | bone marrow | pro-B cell | NA |
| E_03394 | chr7:126416668-126416932 | spleen | B cell | NA |
| E_03407 | chr7:126416668-126416932 | spleen | B cell | NA |
| E_03408 | chr7:126416668-126416932 | spleen | B cell | NA |